Cargando…

Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis

The sofosbuvir-velpatasvir single-tablet regimen (Epclusa) is a newly FDA-approved inhibitor of hepatitis C virus (HCV). This meta-analysis aimed to investigate the safety and efficacy of velpatasvir-sofosbuvir in the treatment of chronic HCV infection. METHODS: A comprehensive literature search of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xiao-Dan, Fu, Xue, He, Yuan-Qun, Li, Chun-Yan, Guo, Meng, Qiao, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	6600
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592351/ https://www.ncbi.nlm.nih.gov/pubmed/36281168 http://dx.doi.org/10.1097/MD.0000000000031183

Ejemplares similares

Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
por: Heo, Jeong, et al.
Publicado: (2023)

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019)

Efficacy and safety of Xiyanping for COVID-2019: A protocol for systematic review and meta-analysis
por: Zhou, Hui, et al.
Publicado: (2020)

Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
por: Shin, Hyun Phil
Publicado: (2023)

Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19
por: Messina, Vincenzo, et al.
Publicado: (2022)

Efficacy and Safety of Sofosbuvir and Velpatasvir Combination for the Treatment of Chronic Hepatitis C in Patients With or Without Cirrhosis
por: Shah, Islam, et al.
Publicado: (2021)

Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C
por: Childs-Kean, Lindsey M, et al.
Publicado: (2019)

Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection
por: Anna, Linda Zignego, et al.
Publicado: (2018)

Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
por: Loo, Jing Hong, et al.
Publicado: (2022)

Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
por: Ruane, Peter, et al.
Publicado: (2019)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
por: Flamm, Steven, et al.
Publicado: (2023)

Value of anti-hepatitis B virus in serum tested by enzyme linked immunosorbent assay 3 in diagnosis of hepatitis B: A protocol for systemic review and meta analysis
por: Fei-fei, Shen, et al.
Publicado: (2021)

Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan
por: Mushtaq, Saima, et al.
Publicado: (2020)

Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
por: Buggisch, Peter, et al.
Publicado: (2019)

Burnout in emergency medicine physicians: A meta-analysis and systematic review
por: Zhang, Qin, et al.
Publicado: (2020)

The efficacy of masks for influenza-like illness in the community: A protocol for systematic review and meta-analysis
por: Wang, Hua, et al.
Publicado: (2020)

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients – short report
por: Piekarska, Anna, et al.
Publicado: (2020)

Perceived neighborhood safety and exercise behavior among community dwellers in Gauteng, South Africa
por: He, Zhifei, et al.
Publicado: (2020)

The safety and effectiveness of rehabilitation exercises on COVID-19 patients: A protocol for systematic review and meta-analysis
por: Gu, Renjun, et al.
Publicado: (2020)

Effectiveness and safety of warm needle acupuncture on chronic renal failure: Protocol for a systematic review and meta-analysis
por: Huang, Cihui, et al.
Publicado: (2020)

Effectiveness and safety of different dressings therapy for pressure injuries: A protocol for systematic reviews and network meta-analysis
por: Cai, Yitong, et al.
Publicado: (2021)

Effectiveness and safety of Tai Chi for anxiety disorder of COVID-19: A protocol of systematic review and meta-analysis
por: Zhang, Shiqiang, et al.
Publicado: (2022)

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
por: Cheng, Pin-Nan, et al.
Publicado: (2021)

Extensile lateral versus sinus tarsi approach for calcaneal fractures: A meta-analysis
por: Peng, Chuangang, et al.
Publicado: (2021)

Training programs in communication skills to improve self-efficacy for health personnel: Protocol for a systematic review and meta-analysis
por: Mata, Ádala Nayana de Sousa, et al.
Publicado: (2019)

Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection
por: Ahmed, Rowan, et al.
Publicado: (2021)

Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir
por: Abi-Saleh, Simon P, et al.
Publicado: (2023)

Safety of locating the tip of a medium-long catheter at the axillary front and clavicle midline: A protocol for systematic review and meta-analysis
por: Zhao, Yali, et al.
Publicado: (2020)

Citrus Fruit Intake Substantially Reduces the Risk of Esophageal Cancer: A Meta-Analysis of Epidemiologic Studies
por: Wang, Anqiang, et al.
Publicado: (2015)

ATP2B1 gene polymorphisms rs2681472 and rs17249754 are associated with susceptibility to hypertension and blood pressure levels: A systematic review and meta-analysis
por: Xie, Ming, et al.
Publicado: (2021)

Prevention and control strategies for children Kashin–Beck disease in China: A systematic review and meta-analysis
por: Yu, Fang-fang, et al.
Publicado: (2019)

Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis
por: Mariantonietta, Pisaturo, et al.
Publicado: (2019)

Dietary meat intake and risk of asthma in children: evidence from a meta-analysis
por: Zhang, Dan, et al.
Publicado: (2020)

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
por: Takehara, Tetsuo, et al.
Publicado: (2018)

Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
por: Higley, Cory, et al.
Publicado: (2020)

Effectiveness and Safety of Sofosbuvir-Velpatasvir in Patients with Cirrhosis Associated with Genotype 3 Hepatitis C Infection in Xinjiang, China
por: Abulitifu, Yilihamu, et al.
Publicado: (2022)

Step Counter Use and Sedentary Time in Adults: A Meta-Analysis
por: Qiu, Shanhu, et al.
Publicado: (2015)

Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems
por: Balasubramanian, Bijal A., et al.
Publicado: (2017)

Patient Safety Walkaround: a communication tool for the reallocation of health service resources: An Italian experience of safety healthcare implementation
por: Ferorelli, Davide, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_88afu4194t7mr1he3stsemfeqo